Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vitamin K cream reduces reactions at the injection site in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta - VIKING study.
Lanzillo R, Moccia M, Carotenuto A, Vacchiano V, Satelliti B, Panetta V, Brescia Morra V. Lanzillo R, et al. Among authors: vacchiano v. Mult Scler. 2015 Aug;21(9):1215-6. doi: 10.1177/1352458514562989. Epub 2015 Feb 6. Mult Scler. 2015. PMID: 25662354 Clinical Trial. No abstract available.
Teeth loss after teriflunomide treatment: Casual or causal? A short case series.
Vacchiano V, Frattaruolo N, Mancinelli L, Foschi M, Carotenuto A, Scandellari C, Piattelli M, Brescia Morra V, Lugaresi A. Vacchiano V, et al. Mult Scler Relat Disord. 2018 Aug;24:120-122. doi: 10.1016/j.msard.2018.06.018. Epub 2018 Jun 30. Mult Scler Relat Disord. 2018. PMID: 29982109
Uric acid: a potential biomarker of multiple sclerosis and of its disability.
Moccia M, Lanzillo R, Palladino R, Russo C, Carotenuto A, Massarelli M, Vacca G, Vacchiano V, Nardone A, Triassi M, Morra VB. Moccia M, et al. Among authors: vacchiano v. Clin Chem Lab Med. 2015 Apr;53(5):753-9. doi: 10.1515/cclm-2014-0744. Clin Chem Lab Med. 2015. PMID: 25241733
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients.
Patti F, De Stefano M, Lavorgna L, Messina S, Chisari CG, Ippolito D, Lanzillo R, Vacchiano V, Realmuto S, Valentino P, Coniglio G, Buccafusca M, Paolicelli D, D'Ambrosio A, Montella P, Brescia Morra V, Savettieri G, Alfano B, Gallo A, Simone I, Viterbo R, Zappia M, Bonavita S, Tedeschi G. Patti F, et al. Among authors: vacchiano v. PLoS One. 2015 Mar 27;10(3):e0120754. doi: 10.1371/journal.pone.0120754. eCollection 2015. PLoS One. 2015. PMID: 25816303 Free PMC article.
First-line disease-modifying drugs in relapsing-remitting multiple sclerosis: an Italian real-life multicenter study on persistence.
Ferraro D, Camera V, Baldi E, Vacchiano V, Curti E, Guareschi A, Malagù S, Montepietra S, Strumia S, Santangelo M, Caniatti L, Foschi M, Lugaresi A, Granella F, Pesci I, Motti L, Neri W, Immovilli P, Montanari E, Vitetta F, Simone AM, Sola P. Ferraro D, et al. Among authors: vacchiano v. Curr Med Res Opin. 2018 Oct;34(10):1803-1807. doi: 10.1080/03007995.2018.1451311. Epub 2018 Apr 12. Curr Med Res Opin. 2018. PMID: 29526118 Free article.
Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study.
Giannoccaro MP, Vacchiano V, Leone M, Camilli F, Zenesini C, Panzera I, Balboni A, Tappatà M, Borghi A, Salvi F, Lugaresi A, Rinaldi R, Di Felice G, Lodi V, Lazzarotto T, Liguori R; ANCOVAX study group. Giannoccaro MP, et al. Among authors: vacchiano v. J Neurol. 2022 Aug;269(8):4000-4012. doi: 10.1007/s00415-022-11142-7. Epub 2022 May 3. J Neurol. 2022. PMID: 35503375 Free PMC article.
66 results